Thor Medical ASA
(STU:8NN)
€
0.40
+0.0035 (+0.88%)
Market Cap: 146.07 Mil
Enterprise Value: 145.35 Mil
PE Ratio: 0
PB Ratio: 3.45
GF Score: 28/100 Nordic Nanovector ASA to Focus on Advancing PARADIGME and Actions to Extend Cash Runway Into 2021 Presentation Transcript
Apr 02, 2020 / 08:00AM GMT
Release Date Price:
€1.13
(+2.86%)
Lars Nieba
Nordic Nanovector ASA - Interim CEO & CTO
Good morning, everybody. I'm Lars Nieba. I'm the interim CEO of Nordic Nanovector, and I will give you an overview about our measures which we have taken in place yesterday. I have with me on the call Jan Egberts, our Chairman; and Malene Brondberg, our VP for IR and Communications. So let me start. We will start with Slide #2.
During our Q4 call, about 4 weeks ago, I said that we will do a strategic review in the company. And today, I would like to share with you our results. So we will exclusively focus on PARADIGME. We will seek to improve PARADIGME protocol and increase recruitment rate of our patients
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot